Provided by Tiger Trade Technology Pte. Ltd.

EyePoint

4.50
+0.02000.45%
Post-market: 4.500.00000.00%19:30 EDT
Volume:3.51M
Turnover:15.73M
Market Cap:387.95M
PE:-1.20
High:4.59
Open:4.44
Low:4.37
Close:4.48
52wk High:19.11
52wk Low:3.95
Shares:86.21M
Float Shares:60.67M
Volume Ratio:0.80
T/O Rate:5.78%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.7642
EPS(LYR):-3.1667
ROE:-148.70%
ROA:-74.85%
PB:2.33
PE(LYR):-1.42

Loading ...

EyePoint grants 20,000 inducement stock options at USD 13.2 per share

Reuters
·
Mar 16

EyePoint Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Mar 16

EyePoint Pharmaceuticals: Strong Clinical Momentum, Favorable Risk‑Reward, and Catalyst‑Rich Path to Duravyu Approval Support Buy Rating

TIPRANKS
·
Mar 10

EyePoint Pharmaceuticals Is Maintained at Buy by Citigroup

Dow Jones
·
Mar 09

EyePoint price target raised to $35 from $31 at Citi

TIPRANKS
·
Mar 09

EyePoint Pharma Bets Big on DuraVu in Pivotal Push

TIPRANKS
·
Mar 07

Analysts Offer Insights on Healthcare Companies: EyePoint Pharmaceuticals (EYPT), Omada Health, Inc. (OMDA) and BridgeBio Oncology Therapeutics (BBOT)

TIPRANKS
·
Mar 06

Stock Track | EyePoint Plummets 13.78% Intraday on Insider Selling by Chief Medical Officer

Stock Track
·
Mar 06

EyePoint Chief Medical Officer Ramiro Ribeiro Disposes of Common Shares

Reuters
·
Mar 06

Guggenheim Remains a Buy on EyePoint Pharmaceuticals (EYPT)

TIPRANKS
·
Mar 05

EyePoint Pharmaceuticals (EYPT) Gets a Buy from RBC Capital

TIPRANKS
·
Mar 05

Chardan Raises Price Target on EyePoint Pharmaceuticals to $29 From $27, Keeps Buy Rating

MT Newswires Live
·
Mar 05

Buy Rating Backed by Margin Upside, Cost Savings, and CRM-Driven Growth Supporting $35 Price Target

TIPRANKS
·
Mar 05

EyePoint Pharmaceuticals Is Maintained at Buy by Chardan Capital

Dow Jones
·
Mar 05

EyePoint price target raised to $29 from $27 at Chardan

TIPRANKS
·
Mar 05

Stock Track | EyePoint Plummets 5.77% Intraday After Q4 Earnings Miss Estimates

Stock Track
·
Mar 04

EyePoint Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Mar 04

EyePoint reports Q4 EPS (81c), consensus (75c)

TIPRANKS
·
Mar 04

EyePoint expects cash to fund operations into Q4 2027

TIPRANKS
·
Mar 04

Earnings Flash (EYPT) EyePoint Posts Q4 Net Loss $0.81 a Share, vs. FactSet Est of $0.77 Loss

MT Newswires Live
·
Mar 04